Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2008-7-16
pubmed:abstractText
Mammographic density is a risk factor for breast cancer. Mammographic density and breast magnetic resonance imaging (MRI) volume (MRIV) assess the amount of fibroglandular tissue in the breast. Mammographic density and MRIV can be modulated with hormonal interventions, suggesting that these imaging modalities may be useful as surrogate endpoint biomarkers for breast cancer chemoprevention trials. We evaluated the effect of raloxifene on mammographic density and MRIV in premenopausal women at increased risk for breast cancer.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-10919644, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-11008908, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-11008909, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-11136842, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-11303594, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-12239257, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-12376506, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-12509398, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-12592245, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-14693739, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-15084246, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-15100340, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-15125012, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-15798166, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-1635085, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-16775175, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-16954474, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-17119062, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-17170217, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-17392385, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-179369, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-8118383, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-9016235, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-9097051, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-9820186, http://linkedlifedata.com/resource/pubmed/commentcorrection/18583470-9865433
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1055-9965
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1696-701
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer.
pubmed:affiliation
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. je95@georgetown.edu
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Clinical Trial, Phase II